Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function
- 31 August 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (5), 507-511
- https://doi.org/10.1016/0002-9149(83)90016-4
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.Circulation, 1982
- Antiarrhythmic efficacy of encainide and quinidine: Validation of a model for drug assessmentThe American Journal of Cardiology, 1981
- Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.Circulation, 1981
- Encainide: A new and potent antiarrhythmic agentAmerican Heart Journal, 1980
- Hemodynamic effects of newer antiarrhythmic drugsAmerican Heart Journal, 1980
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Congestive Heart Failure Caused by Oral DisopyramideNew England Journal of Medicine, 1980
- Effects of oral quinidine on left ventricular performance in normal subjects and patients with congestive cardiomyopathyThe American Journal of Cardiology, 1979
- Analysis of Encainide in Plasma by Radioimmunoassay and High Pressure Liquid ChromatographyTherapeutic Drug Monitoring, 1979
- The comparative inotropic effects of six clinically used antiarrhythmic agentsAmerican Heart Journal, 1972